News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EpiVax, Inc. Tregitope Technology: a Paradigm Shift


3/3/2010 1:02:25 PM

Providence RI (Vocus/PRWEB ) March 2, 2010 -- EpiVax, a paradigm-shifting biotechnology company, takes the road this spring to share news about Tregitope – the small peptides contained in IgG that trigger regulatory T cells – and other cutting-edge science and technology with scientific colleagues. Starting in Asia, EpiVax will be presenting the Tregitope paradigm shift at 10 conferences between March and August 2010. A list of upcoming conferences is presented here below.

Read at PRWEB


comments powered by Disqus
PRWEB
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES